What is Rocio Mandry-Pagan's NPI number?

Rocio Mandry-Pagan's National Provider Identifier (NPI) is 1033277892, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Rocio Mandry-Pagan's specialty?

Rocio Mandry-Pagan is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Rocio Mandry-Pagan located?

Rocio Mandry-Pagan's practice location on file with NPPES is 107 Gonzalez Giusti Ave., Guaynabo, PR 00966.

What is Rocio Mandry-Pagan's phone number?

The practice phone number listed in the NPPES registry for Rocio Mandry-Pagan is (787) 781-8999.

Does Rocio Mandry-Pagan accept Medicare?

Rocio Mandry-Pagan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Rocio Mandry-Pagan's NPI active?

Yes — Rocio Mandry-Pagan's NPI (1033277892) is active in the NPPES registry as of the last update on 2007-07-08.

IndividualActiveAccepts Medicare

Rocio Mandry-Pagan, M.D.

NPI 1033277892 · Dermatology Physician · Guaynabo, PR

Rocio Mandry-Pagan, M.D. is a Dermatology Physician provider in Guaynabo, PR (NPI 1033277892).

Provider details

NPI number: 1033277892
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: Yes
License: 10,769 (PR)

Practice location

107 Gonzalez Giusti Ave.

Caparra Gallery, Suite 309

Guaynabo, PR 00966

Phone: (787) 781-8999

Fax: (787) 792-5925

More PR providers

Mailing address

Po Box 360867

San Juan, PR 00936-0867

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 10,769 (PR)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(72/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,002 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	388	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	290	$89
Destruction of Precancer Skin Growth, 1 Growth17000	107	$65
Destruction of Skin Growth, 1-14 Growths17110	96	$111
Biopsy of Related Skin Growth, First Growth11102	46	$94
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 22 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	121	78
Triamcinolone Acetonide	64	53
Desonide	60	48
Mupirocin	44	38
Doxycycline Hyclate	35	27
Prednisone	30	16
Clobetasol Propionate	26	18
Betamethasone Valerate	24	17

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$835 across 14 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-12-05
Last updated: 2007-07-08

Frequently asked questions

What is Rocio Mandry-Pagan's NPI number?: Rocio Mandry-Pagan's National Provider Identifier (NPI) is 1033277892, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Rocio Mandry-Pagan's specialty?: Rocio Mandry-Pagan is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Rocio Mandry-Pagan located?: Rocio Mandry-Pagan's practice location on file with NPPES is 107 Gonzalez Giusti Ave., Guaynabo, PR 00966.
What is Rocio Mandry-Pagan's phone number?: The practice phone number listed in the NPPES registry for Rocio Mandry-Pagan is (787) 781-8999.
Does Rocio Mandry-Pagan accept Medicare?: Rocio Mandry-Pagan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Rocio Mandry-Pagan's NPI active?: Yes — Rocio Mandry-Pagan's NPI (1033277892) is active in the NPPES registry as of the last update on 2007-07-08.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	388	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	290	$89
Destruction of Precancer Skin Growth, 1 Growth17000	107	$65
Destruction of Skin Growth, 1-14 Growths17110	96	$111
Biopsy of Related Skin Growth, First Growth11102	46	$94
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

121

Triamcinolone Acetonide

Desonide

Mupirocin

Doxycycline Hyclate

Prednisone

Clobetasol Propionate

Betamethasone Valerate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$835 across 14 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments